欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Ras-Raf-MAPK-ERK Pathway-Ras-AM-2383
AM-2383

Chemical Structure : AM-2383

CAS No.: 2791263-84-6

AM-2383 (AM2383)

货号: PC-27366Not For Human Use, Lab Use Only.

AM-2383 is a potent, selective pan-KRAS inhibitor that blocks signaling via both the GDP(off)- and GTP(on)-bound states of KRAS, potently bind to a diverse set of common oncogenic KRAS mutants with IC50 of 2-10 nM in NanoBRET KRAS target engagement assay, also potently bind to KRAS WT (IC50=2 nM).

规格 价格 库存 数量
1 mg ¥1980 In stock
5 mg ¥4980 In stock
10 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

AM-2383 is a potent, selective pan-KRAS inhibitor that blocks signaling via both the GDP(off)- and GTP(on)-bound states of KRAS, potently bind to a diverse set of common oncogenic KRAS mutants with IC50 of 2-10 nM in NanoBRET KRAS target engagement assay, also potently bind to KRAS WT (IC50=2 nM).
AM-2383 shows little activity toward related RAS isoforms (HRAS Coupled Exchange Activity IC50 = 0.320 (>80-fold selectivity); NRAS Coupled Exchange Activity IC50 = 1.60 μM (>400-fold selectivity).
AM-2383 binds to KRAS WT with a KD value of 0.03 nM, with much weaker affinity for HRAS and NRAS with a KD value of 139 nM and 2.6 uM.
AM-2383 potently inhibits ERK phosphorylation across common KRAS mutants (G12D, G12V, & G12C; IC50 = 3-9 nM) across KRAS mutant cell lines.
AM-2383 showsrobust antiproliferative activity (avg. IC50 = 30 nM) across KRAS mutant cell lines, does not impact proliferation in KRASWT or NRAS mutant cell lines.
AM-2383 (100 mg/kg, QD, oral) induces 80% tumor growth inhibition (TGI) in AsPC-1 tumor xenograft model.

物理化学性质&存储条件

分子量 607.68
分子式 C33H36F3N5O3
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

(R)-1-(7-(8-Ethyl-7-fluoro-3-hydroxynaphthalen-1-yl)-8-fluoro-2-(((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)pyrido[4,3-d]pyrimidin-4-yl)-3-methylpiperidin-3-ol

参考文献

1. Wurz RP, et al. J Med Chem. 2026 Jul 23;69(14):17401-17415.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: